General Information of the Compound
Compound ID |
CP0156994
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
1-(9H-Carbazol-4-yloxy)-3-isopropylamino-propan-2-ol
Show/Hide
|
||||||||||||||||||
Synonyms |
1-((9H-Carbazol-4-yl)oxy)-3-(isopropylamino)propan-2-ol
1-(4-Carbazolyloxy)-3-isopropylamino-2-propanol
1-(9H-carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol
1-(9H-carbazol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol
1-(Carbazol-4-yloxy)-3-(isopropylamino)-2-propanol
57775-29-8
BM 51052
BM-51052
BRN 3620576
CCRIS 1047
CHEMBL324665
Carazolol
Carazolol [INN:BAN]
Carazololum [INN-Latin]
Conducton
Conducton hydrochloride
EINECS 260-945-1
Suacron
corazolol
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C18H22N2O2
|
||||||||||||||||||
Molecular Weight |
298.386
|
||||||||||||||||||
Canonical SMILES |
CC(C)NCC(O)COc1cccc2[nH]c3ccccc3c12
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C18H22N2O2/c1-12(2)19-10-13(21)11-22-17-9-5-8-16-18(17)14-6-3-4-7-15(14)20-16/h3-9,12-13,19-21H,10-11H2,1-2H3
Show/Hide
|
||||||||||||||||||
InChIKey |
BQXQGZPYHWWCEB-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
57775-29-8
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06365, Beta-1 adrenergic receptor
Protein ID: PT01494, Beta-2 adrenergic receptor
Clinical Information about the Compound